Manuele Gori

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 9

Top Topics

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Top Venues

Bioengineering (Basel, Switzerland)

International journal of molecular sciences

Biotechnology and bioengineering

This page only lists publications with an associated author ORCID identifier.

Publications

Michele Cicala, Manuele Gori, Paola Balestrieri, Annamaria Altomare, Alessandro Tullio, Simone Di Cola, Sander Dejongh, Maria Giovanna Graziani, Cristiano Pagnini, Simone Carotti, Giuseppe Perrone, Mentore Ribolsi, Marcello Fiorani, Michele P L Guarino, Ricard Farré
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients. International journal of molecular sciences 25 (11) (2024)
Antonio D'Ambrosio, Annamaria Altomare, Tamara Boscarino, Manuele Gori, Paola Balestrieri, Lorenza Putignani, Federica Del Chierico, Simone Carotti, Michele Cicala, Michele Pier Luca Guarino, Vincenzo Piemonte
Mathematical Modeling of Vedolizumab Treatment's Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients. Bioengineering (Basel, Switzerland) 11 (7) (2024)
Antonio D'Ambrosio, Annamaria Altomare, Tamara Boscarino, Manuele Gori, Paola Balestrieri, Lorenza Putignani, Federica Del Chierico, Simone Carotti, Michele Cicala, Michele Pier Luca Guarino, Vincenzo Piemonte
Mathematical Modeling of Vedolizumab Treatment's Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients. Bioengineering (Basel, Switzerland) 11 (7) (2024)
Antonio D'Ambrosio, Annamaria Altomare, Tamara Boscarino, Manuele Gori, Paola Balestrieri, Lorenza Putignani, Federica Del Chierico, Simone Carotti, Michele Cicala, Michele Pier Luca Guarino, Vincenzo Piemonte
Mathematical Modeling of Vedolizumab Treatment's Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients. Bioengineering (Basel, Switzerland) 11 (7) (2024)
Michele Cicala, Manuele Gori, Paola Balestrieri, Annamaria Altomare, Alessandro Tullio, Simone Di Cola, Sander Dejongh, Maria Giovanna Graziani, Cristiano Pagnini, Simone Carotti, Giuseppe Perrone, Mentore Ribolsi, Marcello Fiorani, Michele P L Guarino, Ricard Farré
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients. International journal of molecular sciences 25 (11) (2024)
Manuele Gori, Sara Maria Giannitelli, Gianluca Vadalà, Rocco Papalia, Loredana Zollo, Massimo Sanchez, Marcella Trombetta, Alberto Rainer, Giovanni Di Pino, Vincenzo Denaro
A Soft Zwitterionic Hydrogel as Potential Coating on a Polyimide Surface to Reduce Foreign Body Reaction to Intraneural Electrodes. Molecules (Basel, Switzerland) 27 (10) (2022)
Manuele Gori, Sara Maria Giannitelli, Miranda Torre, Pamela Mozetic, Franca Abbruzzese, Marcella Trombetta, Enrico Traversa, Lorenzo Moroni, Alberto Rainer
Biofabrication of Hepatic Constructs by 3D Bioprinting of a Cell-Laden Thermogel: An Effective Tool to Assess Drug-Induced Hepatotoxic Response. Advanced healthcare materials 9 (21) (2020)
Manuele Gori, Sara Maria Giannitelli, Andrea Zancla, Pamela Mozetic, Marcella Trombetta, Nicolò Merendino, Alberto Rainer
Quercetin and hydroxytyrosol as modulators of hepatic steatosis: A NAFLD-on-a-chip study. Biotechnology and bioengineering 118 (1) (2020)
Manuele Gori, Maria Chiara Simonelli, Sara Maria Giannitelli, Luca Businaro, Marcella Trombetta, Alberto Rainer
Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device. PloS one 11 (7) (2016)
Manuele Gori, Mario Arciello, Clara Balsano
MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma. BioMed research international 2014 (2014)